Potential and Pitfalls of SGLT2 Inhibitors in the Management of Equine Metabolic Syndrome

Dr. David Rendle discusses the use of SGLT2 inhibitors in the management of equine metabolic syndrome. After watching the webinar, you’ll feel confident in knowing when to consider and when to stop treatment with SGLT2 inhibitors.